TCRX TScan Therapeutics, Inc. - Common Stock
$0,99
Cena · Maj 20, 2026
Dane fundamentalne na dzień Maj 6, 2026
Zakres 52 tyg.
$1–$3
6% of range
Ocena Analityków
BUY
13 analysts
Cena Docelowa
$6
+506% upside
P/E (TTM)
-1.0
ROE
-86.6%
Marża Zysku Netto
-1256.8%
TCRX Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$0.99
Kapitalizacja Rynkowa
—
P/E (TTM)
-1.0
EPS (TTM)
$-1.00
Przychody (TTM)
$10M
Stopa dywidendy
—
ROE
-86.6%
D/E Dług/Kapitał
0.3
Zakres 52 tyg.
$1 – $3
TCRX Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$10M
2020-12-31
→
2025-12-31
EPS
$-1.00
2021-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-140M
2021-12-31
→
2025-12-31
Marże
-1256.8%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
TCRX
Mediana porównawcza
P/E (TTM)
-1.0
25.0
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
TCRX
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-1315.4%
—
Net Profit Margin (Marża Zysku Netto)
-1256.8%
-820.5%
ROA
-43.3%
-41.3%
ROE
-86.6%
-63.6%
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
TCRX
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
0.3
0.0
Current Ratio (Wskaźnik bieżący)
8.4
5.7
Quick Ratio (Wskaźnik Szybkości)
8.2
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
TCRX
Mediana porównawcza
Revenue YoY (Przychody R/R)
266.7%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
-8.6%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
56.9%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
TCRX
Mediana porównawcza
TCRX Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
13 analityków
- Mocne kupno 3 23,1%
- Kup 7 53,8%
- Trzymaj 3 23,1%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
4 analityków · 2026-05-15
Mediana
$6.00
← Poniżej wszystkich celów
$0.99
Niski
$5.00
Wysoki
$7.00
Średni cel
$6.00
+506,4%
Średnia cel
$6.00
+506,4%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.02%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $-0.22 | $-0.18 | -0.04% |
| 31 grudnia 2025 | $-0.18 | $-0.25 | 0.07% |
| 30 września 2025 | $-0.28 | $-0.30 | 0.02% |
| 30 czerwca 2025 | $-0.28 | $-0.29 | 0.01% |
| 31 marca 2025 | $-0.26 | $-0.29 | 0.03% |
Porównanie jednostek Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| TCRX | — | -1.0 | 266.7% | -1256.8% | -86.6% | — |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | — |
| SERA | — | -4.4 | 5.2% | -39417.3% | -39.0% | — |
| MNOV | $64M | -5.5 | — | -2928.8% | -27.1% | — |
| LIXT | $35M | -3.1 | — | — | -117.9% | — |
| ANVS | $94M | -2.5 | — | — | -164.0% | — |
| SGMO | — | -1.0 | -31.6% | — | — | — |
| FRMM | — | — | — | -6881.3% | -368.1% | — |
| PDSB | — | -1.0 | — | — | — | — |
| DWTX | $124M | -0.6 | 123.6% | — | -83.8% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $10M | $3M | $21M | $14M | $10M | $1M | |
| R&D Expense | $114M | $107M | $88M | $60M | $45M | $21M | |
| SG&A Expense | $32M | $30M | $26M | $20M | $14M | $7M | |
| Operating Expenses | $146M | $138M | $115M | $80M | $59M | $27M | |
| Operating Income | $-136M | $-135M | $-93M | $-67M | $-49M | $-26M | |
| Interest Expense | $3M | $4M | $4M | $1M | · | · | |
| Other Non-op | $6M | $7M | $4M | $415.0K | $16.0K | · | |
| Income Tax | $0 | · | · | · | · | · | |
| Net Income | $-130M | $-127M | $-89M | $-66M | $-49M | $-26M | |
| EPS (Basic) | $-1.00 | $-1.14 | $-1.36 | $-2.75 | $-4.17 | · | |
| EPS (Diluted) | $-1.00 | $-1.14 | $-1.36 | $-2.75 | $-4.17 | · | |
| Shares (Basic) | 129,777,415 | 111,990,417 | 65,599,858 | 24,048,267 | 11,662,672 | · | |
| Shares (Diluted) | 129,777,415 | 111,990,417 | 65,599,858 | 24,048,267 | 11,662,672 | · | |
| EBITDA | $-136M | $-135M | · | $-67M | $-49M | · |
Bilans 21
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $152M | $179M | $133M | $120M | $161M | $35M | |
| Short-term Investments | · | $111M | $59M | · | · | · | |
| Prepaid Expense | $5M | $3M | $2M | $4M | $4M | $2M | |
| Current Assets | $157M | $293M | $194M | $124M | $166M | $36M | |
| PP&E (Net) | $9M | $7M | $8M | $10M | $12M | $6M | |
| PP&E (Gross) | $30M | $26M | $22M | $20M | $17M | $7M | |
| Accum. Depreciation | $22M | $19M | $15M | $10M | $5M | $2M | |
| Total Assets | $229M | $371M | $272M | $199M | $188M | $50M | |
| Accounts Payable | $1M | $4M | $2M | $3M | $2M | $3M | |
| Current Liabilities | $19M | $36M | $30M | $17M | $21M | $17M | |
| Capital Leases | $54M | $61M | $59M | $53M | $4M | $6M | |
| Other Non-current Liabilities | · | $135.0K | · | $49.0K | $97.0K | $238.0K | |
| Total Liabilities | $106M | $130M | $121M | $100M | $27M | $33M | |
| Long-term Debt | $33M | $32M | $30M | $29M | · | · | |
| Total Debt | $33M | $32M | · | $29M | · | · | |
| Common Stock | · | · | · | · | · | $1.0K | |
| Retained Earnings | $-505M | $-375M | $-248M | $-158M | $-92M | $-44M | |
| AOCI | · | $51.0K | · | · | · | · | |
| Stockholders' Equity | $123M | $241M | $151M | $99M | $161M | $-42M | |
| Liabilities + Equity | $229M | $371M | $272M | $199M | $188M | $50M | |
| Shares Outstanding | 52,625,035 | 52,314,039 | · | 19,082,820 | 18,764,463 | 1,135,858 |
Przepływy pieniężne 12
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $3M | $4M | $5M | $5M | $3M | $1M | |
| Stock-based Comp | $12M | $10M | $5M | $5M | $3M | $515.0K | |
| Operating Cash Flow | $-135M | $-111M | $-61M | $-67M | $-49M | $-3M | |
| CapEx | $4M | $4M | $3M | $4M | $10M | $4M | |
| Investing Cash Flow | $109M | $-53M | $-61M | $-4M | $-10M | $-4M | |
| Debt Issued | · | · | · | $29M | · | · | |
| Net Debt Issued | · | · | · | $29M | · | · | |
| Stock Issued | · | $33M | $42M | $193.0K | · | · | |
| Net Stock Activity | · | $33M | · | $193.0K | · | · | |
| Financing Cash Flow | $-336.0K | $209M | $135M | $29M | $190M | $288.0K | |
| Net Change in Cash | $-26M | $45M | $13M | $-41M | $131M | $-7M | |
| Free Cash Flow | $-140M | $-115M | · | $-71M | $-59M | · |
Rentowność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -1315.4% | -4787.7% | · | -492.3% | -479.6% | · | |
| Net Margin | -1256.8% | -4527.7% | · | -489.3% | -479.5% | · | |
| EBITDA Margin | -1315.4% | -4787.7% | · | -492.3% | -479.6% | · | |
| ROA | -43.3% | -39.6% | · | -34.2% | -40.9% | · | |
| ROE | -86.6% | -54.2% | · | -61.3% | -29.0% | · |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 8.4 | 8.1 | · | 7.2 | 7.8 | · | |
| Quick Ratio | 8.2 | 8.1 | · | 6.9 | 7.6 | · | |
| Debt / Equity | 0.3 | 0.1 | · | 0.3 | · | · | |
| LT Debt / Equity | 0.3 | 0.1 | · | 0.3 | · | · | |
| Interest Coverage | -49.0 | -36.9 | · | -56.7 | · | · |
Efektywność 1
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | · |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 266.7% | -86.6% | 55.5% | 33.5% | 834.7% | · | |
| Revenue CAGR 3Y | -8.6% | -34.8% | 168.7% | · | · | · | |
| Revenue CAGR 5Y | 56.9% | · | · | · | · | · |
Wycena (TTM) 4
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $3M | $21M | $14M | $10M | · | |
| Net Income TTM | $-130M | $-127M | $-89M | $-66M | $-49M | · | |
| P/E | -1.0 | -2.7 | -4.3 | -0.6 | -1.1 | · | |
| Earnings Yield | -100.0% | -37.5% | -23.3% | -177.4% | -92.7% | · |
Rachunek zysków i strat 13
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $982.0K | $3M | $3M | $3M | $2M | $665.0K | $1M | $536.0K | $566.0K | $7M | $4M | $3M | $7M | $3M | $3M | $4M | |
| R&D Expense | $22M | $20M | $32M | $33M | $30M | $29M | $26M | $27M | $25M | $22M | $23M | $21M | $22M | $16M | $15M | $14M | |
| SG&A Expense | $8M | $6M | $8M | $9M | $9M | $8M | $7M | $8M | $7M | $6M | $6M | $7M | $8M | $6M | $5M | $5M | |
| Operating Expenses | $30M | $26M | $40M | $42M | $38M | $37M | $34M | $35M | $32M | $29M | $29M | $28M | $30M | $22M | $20M | $19M | |
| Operating Income | $-29M | $-24M | $-37M | $-39M | $-36M | $-37M | $-33M | $-34M | $-31M | $-21M | $-25M | $-25M | $-23M | $-19M | $-17M | $-15M | |
| Interest Expense | $689.0K | $702.0K | $699.0K | $689.0K | $679.0K | $784.0K | $958.0K | $952.0K | $959.0K | $852.0K | $982.0K | $969.0K | $956.0K | $975.0K | $201.0K | · | |
| Other Non-op | $473.0K | $881.0K | $1M | $2M | $2M | $903.0K | $3M | $2M | $1M | $2M | $2M | $565.0K | $180.0K | $-74.0K | $333.0K | $149.0K | |
| Net Income | $-29M | $-23M | $-36M | $-37M | $-34M | $-36M | $-30M | $-32M | $-30M | $-20M | $-23M | $-24M | $-23M | $-19M | $-16M | $-15M | |
| EPS (Basic) | $-0.22 | $-0.18 | $-0.28 | $-0.28 | $-0.26 | $-0.29 | $-0.25 | $-0.28 | $-0.32 | $0.32 | $-0.24 | $-0.51 | $-0.93 | $-0.78 | $-0.67 | $-0.63 | |
| EPS (Diluted) | $-0.22 | $-0.18 | $-0.28 | $-0.28 | $-0.26 | $-0.29 | $-0.25 | $-0.28 | $-0.32 | $0.32 | $-0.24 | $-0.51 | $-0.93 | $-0.78 | $-0.67 | $-0.63 | |
| Shares (Basic) | 129,913,376 | -259,467,546 | 129,835,938 | 129,730,451 | 129,678,572 | -215,011,195 | 118,700,362 | 113,425,357 | 94,875,893 | -100,664,604 | 94,829,844 | 47,208,664 | 24,225,954 | -48,063,987 | 24,073,935 | 24,063,677 | |
| Shares (Diluted) | 129,913,376 | -259,467,546 | 129,835,938 | 129,730,451 | 129,678,572 | -215,011,195 | 118,700,362 | 113,425,357 | 94,875,893 | -100,664,604 | 94,829,844 | 47,208,664 | 24,225,954 | -48,063,987 | 24,073,935 | 24,063,677 | |
| EBITDA | $-29M | · | $-37M | $-39M | $-36M | · | $-33M | $-34M | $-31M | · | $-25M | $-25M | $-23M | · | $-17M | $-15M |
Bilans 21
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $128M | $152M | $170M | $169M | $154M | $179M | $133M | $242M | $141M | $133M | $155M | $209M | $96M | $120M | $137M | $126M | |
| Short-term Investments | · | · | $15M | $49M | $98M | $111M | $138M | $56M | $22M | $59M | $60M | · | · | · | · | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $32M | · | · | · | · | |
| Prepaid Expense | $5M | $5M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $5M | $4M | $4M | $4M | |
| Current Assets | $133M | $157M | $188M | $221M | $255M | $293M | $274M | $300M | $165M | $194M | $218M | $242M | $101M | $124M | $141M | $129M | |
| PP&E (Net) | $8M | $9M | $9M | $10M | $8M | $7M | $7M | $8M | $7M | $8M | $9M | $8M | $9M | $10M | $10M | $11M | |
| PP&E (Gross) | · | $30M | · | · | · | $26M | · | · | · | $22M | · | · | · | $20M | · | · | |
| Accum. Depreciation | · | $22M | · | · | · | $19M | · | · | · | $15M | · | · | · | $10M | · | · | |
| Total Assets | $202M | $229M | $262M | $299M | $333M | $371M | $348M | $375M | $241M | $272M | $291M | $317M | $174M | $199M | $165M | $152M | |
| Accounts Payable | $2M | $1M | $6M | $5M | $5M | $4M | $4M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Current Liabilities | $20M | $19M | $29M | $31M | $30M | $36M | $29M | $39M | $31M | $30M | $33M | $35M | $14M | $17M | $17M | $17M | |
| Capital Leases | $52M | $54M | $56M | $58M | $60M | $61M | $56M | $57M | $58M | $59M | $53M | $54M | $52M | $53M | $3M | $3M | |
| Other Non-current Liabilities | · | · | $278.0K | $113.0K | $124.0K | $135.0K | $146.0K | · | · | · | $12.0K | $24.0K | $36.0K | $49.0K | $97.0K | $97.0K | |
| Total Liabilities | $105M | $106M | $118M | $122M | $123M | $130M | $119M | $120M | $118M | $121M | $122M | $126M | $96M | $100M | $49M | $21M | |
| Long-term Debt | $33M | $33M | $32M | $32M | $32M | · | $31M | $30M | $30M | $30M | $30M | $30M | $30M | · | $29M | · | |
| Total Debt | $33M | · | $32M | $32M | $32M | · | $31M | $30M | $30M | · | $30M | $30M | $30M | · | $29M | · | |
| Retained Earnings | $-534M | $-505M | $-482M | $-446M | $-409M | $-375M | $-339M | $-309M | $-278M | $-248M | $-228M | $-205M | $-181M | $-158M | $-140M | $-123M | |
| AOCI | · | · | $2.0K | $-4.0K | $-4.0K | $51.0K | · | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $97M | $123M | $144M | $177M | $210M | $241M | $229M | $255M | $123M | $151M | $169M | $191M | $78M | $99M | $117M | $132M | |
| Liabilities + Equity | $202M | $229M | $262M | $299M | $333M | $371M | $348M | $375M | $241M | $272M | $291M | $317M | $174M | $199M | $165M | $152M | |
| Shares Outstanding | 55,824,722 | · | · | · | · | · | · | · | · | · | 43,546,528 | 43,542,178 | 19,480,729 | · | · | 18,929,834 |
Przepływy pieniężne 9
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Operating Cash Flow | $-24M | $-32M | $-32M | $-33M | $-38M | $-27M | $-28M | $-26M | $-29M | $-24M | $8M | $-22M | $-24M | $-16M | $-17M | $-13M | |
| CapEx | $70.0K | $171.0K | $1M | $1M | $2M | $888.0K | $1M | $862.0K | $705.0K | $469.0K | $1M | $420.0K | $838.0K | $1M | $424.0K | $2M | |
| Investing Cash Flow | $-70.0K | $15M | $33M | $48M | $14M | $27M | $-82M | $-34M | $36M | $2M | $-61M | $-420.0K | $-838.0K | $-1M | $-424.0K | $-2M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Issued | · | · | · | · | · | $0 | $0 | · | · | $0 | $-186.0K | · | · | · | · | · | |
| Financing Cash Flow | · | $73.0K | $0 | $116.0K | $-525.0K | $46M | $1M | $162M | $258.0K | $19.0K | $-252.0K | · | · | $108.0K | $29M | $31.0K | |
| Net Change in Cash | $-24M | $-17M | $112.0K | $15M | $-25M | $46M | $-109M | $102M | $7M | $-22M | $-54M | $113M | $-24M | $-17M | $12M | $-15M | |
| Free Cash Flow | $-24M | · | · | · | $-39M | · | · | · | $-30M | · | · | · | $-24M | · | · | · |
Rentowność 5
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2967.3% | · | -1475.6% | -1256.6% | -1669.7% | · | -3109.8% | -6364.6% | -5542.9% | · | -636.7% | -781.8% | -334.3% | · | -492.9% | -375.9% | |
| Net Margin | -2919.1% | · | -1422.1% | -1201.3% | -1572.0% | · | -2849.1% | -5906.9% | -5325.4% | · | -591.6% | -763.8% | -331.7% | · | -483.0% | -372.2% | |
| EBITDA Margin | -2967.3% | · | -1475.6% | -1256.6% | -1669.7% | · | -3109.8% | -6364.6% | -5542.9% | · | -636.7% | -781.8% | -334.3% | · | -492.9% | -375.9% | |
| ROA | -10.7% | · | -11.7% | -11.0% | -11.9% | · | -9.3% | -9.2% | -14.5% | · | -10.1% | -10.2% | -13.2% | · | -8.8% | -10.7% | |
| ROE | -18.7% | · | -19.1% | -17.1% | -20.5% | · | -15.0% | -14.2% | -30.0% | · | -16.1% | -14.9% | -20.2% | · | -11.2% | -42.2% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.6 | · | 6.4 | 7.1 | 8.5 | · | 9.6 | 7.8 | 5.2 | · | 6.6 | 6.9 | 7.2 | · | 8.5 | 7.5 | |
| Quick Ratio | 6.4 | · | 6.3 | 7.0 | 8.4 | · | 9.5 | 7.7 | 5.2 | · | 6.5 | 6.9 | 6.8 | · | 8.3 | 7.3 | |
| Debt / Equity | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.4 | · | 0.2 | · | |
| LT Debt / Equity | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.4 | · | 0.2 | · | |
| Interest Coverage | -42.3 | · | -53.0 | -56.1 | -53.4 | · | -34.1 | -35.8 | -32.7 | · | -25.2 | -25.4 | -23.8 | · | -82.5 | · |
Efektywność 2
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.2 | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9M | · | $9M | $7M | $4M | · | $6M | $8M | $14M | · | $17M | $17M | $17M | · | $13M | $12M | |
| Net Income TTM | $-135M | · | $-137M | $-133M | $-126M | · | $-115M | $-109M | $-100M | · | $-86M | $-78M | $-70M | · | $-63M | $-58M | |
| Market Cap | $56M | · | · | · | · | · | · | · | · | · | $111M | $109M | $41M | · | · | $60M | |
| Enterprise Value | $-39M | · | · | · | · | · | · | · | · | · | $-74M | $-70M | $-25M | · | · | · | |
| P/E | -1.0 | · | -1.7 | -1.4 | -1.2 | · | -4.6 | -4.3 | -4.0 | · | -1.1 | -0.9 | -0.7 | · | -1.1 | -0.3 | |
| P/S | 6.5 | · | · | · | · | · | · | · | · | · | 6.5 | 6.3 | 2.4 | · | · | 4.8 | |
| P/B | 0.6 | · | · | · | · | · | · | · | · | · | 0.7 | 0.6 | 0.5 | · | · | 0.5 | |
| P / Tangible Book | 0.6 | · | · | · | · | · | · | · | · | · | 0.7 | 0.6 | 0.5 | · | · | 0.5 | |
| P / Cash Flow | -2.3 | · | · | · | · | · | · | · | · | · | · | · | -1.7 | · | · | · | |
| P / FCF | -2.3 | · | · | · | · | · | · | · | · | · | · | · | -1.7 | · | · | · | |
| EV / EBITDA | 1.3 | · | · | · | · | · | · | · | · | · | 3.0 | 2.9 | 1.1 | · | · | · | |
| EV / FCF | 1.6 | · | · | · | · | · | · | · | · | · | · | · | 1.0 | · | · | · | |
| EV / Revenue | -4.5 | · | · | · | · | · | · | · | · | · | -4.3 | -4.0 | -1.5 | · | · | · | |
| Earnings Yield | -103.0% | · | -58.8% | -73.8% | -80.4% | · | -21.9% | -23.1% | -25.2% | · | -91.8% | -109.6% | -138.1% | · | -90.8% | -311.3% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $10M | $3M | $21M | $14M | $10M |
| Marża Operacyjna % | -1315.4% | -4787.7% | — | -492.3% | -479.6% |
| Zysk netto | $-130M | $-127M | $-89M | $-66M | $-49M |
| Rozwodniony EPS | $-1.00 | $-1.14 | $-1.36 | $-2.75 | $-4.17 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.3 | 0.1 | — | 0.3 | — |
| Wskaźnik bieżący | 8.4 | 8.1 | — | 7.2 | 7.8 |
| Wskaźnik Szybkości | 8.2 | 8.1 | — | 6.9 | 7.6 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-140M | $-115M | — | $-71M | $-59M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.